Andrew Hollman Meyer

Chief Business Officer, Janux Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Jan 2, 2026

Companies

Janux Therapeutics, Inc.Chief Business Officer −$0.7M

Trades

JANX Sold 1,879 shares at $13.73 $0.0M Jan 2

JANX Sold 3,333 shares at $32.98 · planned $0.1M Dec 1

JANX Sold 3,333 shares at $30.00 · planned $0.1M Nov 14

JANX Sold 16,665 shares at $30.06 · planned $0.5M Oct 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.